Form 4: Agilon Health Executive Veeral Desai Reports Stock Transactions

Veeral Desai, Chief Strategy & Development Officer at Agilon Health, reports the vesting and settlement of performance-based restricted stock units (PSUs) and shares withheld for tax obligations.

Summary

• On March 14, 2024, Veeral Desai, Chief Strategy & Development Officer of Agilon Health, Inc., had 11,956 shares of common stock vest as part of a performance-based restricted stock unit (PSU) award granted on April 14, 2021.
• The vesting was based on Agilon Health's revenue and adjusted EBITDA goals from January 1, 2021, through December 31, 2023, with a total attainment of 100%.
• Additionally, 4,900 shares were withheld by the issuer to cover income tax obligations related to the PSU settlement at a price of $5.23 per share.
• Following these transactions, Desai directly owns 306,641 shares of common stock, which includes restricted stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The vesting of PSUs suggests the company met its performance targets, which is a positive sign. However, the tax withholding is a neutral event.

Positives

• The vesting of PSUs indicates that Agilon Health achieved its performance goals related to revenue and adjusted EBITDA over the specified three-year period.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, which can be an indicator of management's confidence in the company's performance and future prospects.

Stakeholder Impact

• Shareholders may view the PSU vesting as a positive sign, indicating that management is incentivized to achieve company goals.
• The tax withholding has no direct impact on stakeholders.

Key Dates